Precision Medicine Market Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030
In the developing field of
precision medicine, the treatment is planned in accordance with the patient's
genetic profile, way of life, and environment. Due to the successful outcomes
of precision medicine in the treatment of cancer, it has grown in popularity.
Because big data analysis and the
IT sector are expanding, it is anticipated that the cost and time needed to
develop new precision medicines will decrease. The creation of new, precise
medications will aid in offering the best prescription to enhance patients'
health. Numerous genetic tests and diagnostic procedures that are to be used to
provide precision medicines generate a significant amount of useful data needed
for tailored prescriptions. Precision
Medicine Market Big data analysis and IT are able to crunch,
analyse, and store the necessary data, enabling doctors to practise precision
medicine. The government funds major industry players who are working to
develop bioinformatics technology for applications in precision medicine
research.
During the forecast period, the Precision
Medicine market growth is
anticipated to be driven by rising technological advancements, such as the
introduction of diagnostic tools that will assist doctors in evaluating or
carrying out proper diagnosis of a disease and then guiding the patients with
appropriate therapy. As an illustration, the leading provider of medical
genetics, Invitae Corporation, announced the availability of FusionPlex Dx and
LiquidPlex Dx in Europe on February 16, 2022. These products are a part of the
company's market-leading Anchored Multiplex PCR Chemistry in-vitro diagnostic
(IVD) products. One of the top suppliers of superior innovation for precision
oncology in the fight against cancer is Invitae. More patients will be able to
access the appropriate cancer therapy at the appropriate time thanks to the
FusionPlex and LiquidPlex tests.
Comments
Post a Comment